Skip to main content

Advertisement

Table 2 Baseline characteristics of the four groups

From: Effect of diabetic retinopathy and diabetes on the intraocular straylight in pseudophakic eyes

  Group 1 (26 eyes) Group 2 (25 eyes) Group 3 (21 eyes) Group 4 (21 eyes)
Age (years) 68.96 ± 1.40 (55–79) 71.40 ± 1.18 (57–82) 60.91 ± 1.61 (45–73) 63.95 ± 1.80 (51–77)
HbA1c (%) - 6.67 ± 0.14 (5.90–8.20) 6.40 ± 0.13 (5.20–8.10) 6.99 ± 0.18 (5.80–8.70)
Duration of DM (years) - 22.69 ± 1.18 (13–34) 13.86 ± 1.02 (5–21) 16.10 ± 0.87 (8–23)
Central macular thickness (μm) 222.77 ± 2.74 (189–242) 217.36 ± 2.06 (197–241) 218.14 ± 2.78 (198–242) 225.43 ± 3.28 (198–250)
Preoperative straylight (log(s)) 2.08 ± 0.05 (1.56–2.37) 2.18 ± 0.04 (1.65–2.35) 2.19 ± 0.04 (1.48–2.36) 2.13 ± 0.04 (1.56–2.36)
Preoperative BCVA (LogMAR) 0.48 ± 0.04 (0.20–0.90) 0.48 ± 0.03 (0.30–0.70) 0.56 ± 0.05 (0.20–1.00) 0.58 ± 0.04 (0.30–1.00)
Postoperative straylight (log(s)) 1.21 ± 0.04 (0.68–1.43) 1.44 ± 0.06 (1.14–2.03) 1.45 ± 0.03 (1.19–1.69) 1.70 ± 0.09 (1.16–2.24)
Postoperative BCVA (LogMAR) 0.08 ± 0.01 (0.00–0.18) 0.10 ± 0.01 (0.00–0.18) 0.10 ± 0.02 (0.00–0.18) 0.14 ± 0.02 (0.00–0.30)
  1. Data in the table are presented as means ± standard errors
  2. HbA1c = hemoglobin A1c, DM = diabetes mellitus, BCVA = best corrected visual acuity